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The immune response of guinea pigs to poly-L-lysine (PLL)  1 and hapten conjugates 
of this polymer is predicated upon the presence of an autosomal dominant gene which 
is referred to as the "PLL gene" (1-3). This same gene also determines the immune 
response of guinea pigs to a copolymer of L-lysine and l~-giutamic acid (GL) and its 
hapten conjugates, although no cross-reactivity could  be detected between anfi-GL 
and  anti-2,4-dinitrophenyl  PLL (DNP-PLL)  antibodies  (4).  Thus,  a  varying per- 
centage of random-bred Harfley strain guinea pigs, depending upon their origin,  and 
all strain 2  guinea pigs immunized with DNP-PLL, GL, or DNP-GL in complete 
Freund's adjuvant produce high levels of specific antibodies and also develop strong 
delayed  hypersensitivity  reactions  when  challenged  with  the  immunizing  antigen 
intradermaUy (4). These guinea pigs which possess  the PLL gene are referred to as 
"responder"  animals.  "Nonresponders"  lacking  the  PLL  gene  include  a  varying 
percentage of random-bred Harfley strain guinea pigs and all strain 13 guinea pigs. 
The manner in which the PLL gene excercises its control of the immune response 
to these antigens is not known but appears to involve the recognition  of a  critical 
number of lysyl residues  which characterize the structure of both PLL and GL and 
their hapten conjugates (5). In recent years, observations dealing with the control of 
specific immune responses  have been extended to several other immune systems in 
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1  A bbreoiagons used in this paper: DNP, 2,4-dinitrophenyl; DNP-GL, 2,4-dinitrophenyl 
copolymer of lysine and glutamic acid; DNP-PLL,  2,4-dinitrophenyl poly-L-lysine;  EACA, 
E-aminocaproic acid; GL, copolymer of lysine and glutamic acid; (H, G)-A-L, synthetic poly- 
pep  fide containing  random sequences of L-histidine and L-glutamic acid on a backbone of 
n,L-alanine and L-lysine; HVL, half value layer; MEM, Eagle's minimum essential medium; 
(Phe G)-A-L, synthetic polypepfide containing random sequences of I~, phenylalanine and 
z-glutamie acid; PLL,  poly-z-lysine; POPOP, 1,4-bis[2-(5-phenyloxzolyl)] benzene; PPO, 
2,5-diphenyloxazole; (T,  G)-A-L, synthetic  polypeptide  containing random sequences of 
L-tyrosine and L-lysine. 
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mice  (6-8), rabbits  (9),  and rats  (10, 11). Thus,  the  immunogenicity for mice  of 
branched synthetic polypeptides containing random sequences  of T.-tyrosine, or L- 
histidine,  or r,-phenylalanine,  and L-glutamic acid on a backbone of D, L-alanlne and 
L-lysine  ( IT, G)  -A-L, (H, G)  -A-L, (PheG)-A-L] has been  shown to  be largely determined 
either by single dominant genes at a single locus, Ir-1, or by three closely linked genes 
(12). The immune response  of mice to a random copolymer of r.-glutamic acid and 
L-lysine containing 5 % L-alanine is also under the control of another dominant gene 
(8). In addition, the ability to recognize porcine lactic dehydrogenase  isoenzyrnes as 
antigens has been reported to be under simple genetic control in rats and rabbits (10). 
The discovery within a short time of several  specific systems  under genetic control 
indicates  that genes affecting specific immune responses are not rare. However, these 
observations  did not further our understanding of the process  controlled by these 
genes. In order to understand the mode of action of genes concerned  with specific 
immune responses, it is essential to identify the cell population and the cell type where 
the process controlled by the genes is expressed and to recognize how these cells are 
concerned with specific immune responses. One general method of achieving this goal 
is  to transfer various types of cell populations from genetic responder animals  into 
animals lacking the genes necessary for the response. Tyan et al. (13) have reported 
the successful  transfer of the ability  to respond to  (T, G)-A-L to irradiated non- 
responder Call parental  recipients  with  adult unfractionated spleen  cells  or  with 
fetal liver cells from (C57B1 ×  C~-I) Fl responder mice. 
The present study is concerned with the transfer of the process controlled by 
the PLL gene to genetic nonresponder guinea pigs with cell populations derived 
from responder animals. In a first series of experiments, the capacity to form an 
immune response to DNP-PLL has  been transferred successfully to lethally 
irradiated nonresponder Hartley strain  guinea pigs with bone marrow trans- 
plants from allogeneic Hartley strain responder animals. However, in the course 
of these experiments many of the cell transfer recipients developed a  severe 
graft versus host reaction which contributed to the high mortality observed in 
these animals. Moreover, lymph node cell populations containing large numbers 
of immunocompetent ceils could not be used in these transfer experiments be- 
cause of unavoidable homologous disease. 
Use was therefore made in a  second series of experiments of the difference 
between the two inbred strains of guinea pigs, 2 and 13, in their ability to re- 
spond to PLL antigens. As would be expected for a  process controlled by a 
dominant genetic factor, all (2 X  13) F1 guinea pigs are able to respond to hap- 
ten-PLL conjugates.  ~ Since (2  X  13)  F1 cells carry all the histocompatibility 
antigens present in both parental strains, the (2  X  13) F1 immunocompetent 
ceil population cannot recognize parental strains. On the other hand, lethally 
irradiated recipient strain 13 guinea pigs cannot readily reject transferred (2 X 
13) F1 cells. Strain 13 guinea pigs can be lethally irradiated and protected with 
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syngeneic bone marrow graft while they are simultaneously  immunologically re- 
constituted with (2  X  13) Ft lymph node and spleen cells. In this system, a 
study can be made of the ability of (2 X  13) F1 bone marrow or lymph node and 
spleen cell populations to transfer to lethally irradiated nonresponder strain 13 
parental guinea pigs the capacity to respond to antigens, the immunogenicity  of 
which is determined by the PLL gene, without interference from graft versus 
host reactions. The transfer of the capacity to respond to DNP-PLL was in- 
vestigated, but, in addition, the transfer of responsiveness to a DI~P conjugate 
of a copolymer of L-glutamic and L-lysine (DNP-GL), the {mmunogenicity of 
which is also controlled by the PLL gene, was studied. The use of DNP-GL in 
these experiments presents certain advantages because of its negligible net elec- 
tric charge. When electrostatically complexed with {mmunogenic carriers, posi- 
tively charged DNP-PLL can behave as a hapten and can elicit the formation of 
anti-DNP  antibodies in nonresponder guinea pigs (14).  Moreover, it has re- 
cently been shown that mycobacterial adjuvants, if used in very large amounts, 
can also act as immunogenic carriers and that nonresponder strain 13 guinea 
pigs immunized with positively charged DNP-PLL and 10 mg of mycobacteria/ 
ml of adjuvant may produce small, but significant, levels of anti-DNP anti- 
bodies, in the absence of any evidence of cellular immunity (15). In contrast, 
repeated  studies  (15,  16)  have demonstrated that nonresponder Hartley or 
strain 13 guinea pigs immunized with DNP-GL and the small amount of myco- 
bacteria generally used in conventional Freund's adjuvant fail to produce de- 
tectable serum levels of anti-DNP antibodies. Thus, when DNP-GL and small 
amounts of mycobacteria are used as immunizing antigens, a successful transfer 
of the process controlled by the PLL gene to nonresponder guinea pigs can be 
unequivocally demonstrated by the development of delayed sensitivity to DNP- 
GL and/or by the formation of anti-DNP antibodies. In these experiments the 
ability to respond to DNP-PLL and to DNP-GL has been successfully trans- 
ferred to lethally irradiated strain 13 guinea pigs with (2 X  13) F1 bone marrow 
or lymph node and spleen cell populations. 
Mantels ¢~ Methods 
Polypept~e~.--Two poly-L-lyslne  HBr (PLL) preparations  with average molecular  weights 
of 90,000 and 110,500 respectively, and a copolymer of T.-glutamic acid and L-lysine (GL) 
with an average molecular weight of 115~000 and a 50:40 molar ratio of glutamic acid to 
lysine, were used. These polypeptides  were purchased from Pilot Chemicals  Inc., Watertown, 
Mass. 
The polypeptides were reacted with 2,4-dinitrofluorobenzene  as described (4), and the 
following conjugates were prepared:DNP~-PLL, DNP~-PLL, and  DNP3s-GL. The sub- 
scripts refer to the average  number of DNP groups per molecule. 
Other Reigns.---Complete Freund's adjuvant was purchased from Difco Laboratories, 
Inc., Detroit, Mich. and contained 0.5  mg/ml  Mycoba~terium b~yr~.um (Dffco complete 
adjuvant) or was prepared by adding  killed  Mycob~Jerium tu/~erc~osis  to incomplete  Freund's 
adjuvant in a final concentration  of 2 mg/ml (M. tub~'c~osls  adjuvant). II10  TRANSFER  OF  RESPONSIVENESS 
Eagle's  minimum essential medium  (MEM),  penicillin,  and  gintamine were  purchased 
from Grand Island Biological Co., Grand Island, N.Y. 
Hydroxide  of  Hyamlne  10X,  PPO  (2,5-diphenyloxazole),  and  dimethyl  POPOP  (1,4- 
bis[2-(4-methyl-5-phenyloxazolyl)] benzene were all purchased from Packard Instrument Co., 
Inc., Downers Grove, Ilk 
Immunization  Procedure  to Determine Responder Status of ttartley Guinea Pigs.--Random- 
bred Hartley strain guinea pigs weighing 300--400 g  were purchased from Carom Research 
Laboratories, Inc., Wayne, N.J. These animals were immunized with a  total of i00 #g of GL 
in Difco complete adjuvant. 0.1 ml of emulsion containing 50#g of the copolymer was injected 
into the left front and hind footpads; the right footpads were saved for subsequent immuniza- 
tions. 10 days after immunization, all animals were skin tested with 50 #g of GL and 14 days 
after immunization with 10/~g of GL.  Animals showing consistently severe delayed  hyper- 
TABLE  I 
Effect of Allogenelc Bone Marrow Transplant on Mortality from Irradiation 
(750 r) of Random-Bred ttartley Strain Guinea Pigs 
No. of animals 
Bone marrow transplant  Survival 
(Mean no. of cells transferred  Mortality 
and range)  median  range 
%  days  days 
22  none  2~2"  100  8  5-10 
95  7.95  X  10  s  75/~5  79  19  6-51 
(2.8  X  1OS-18 X  10  s) 
* Of these 75 animals, 7 died  from acute radiation sickness, 7 from marrow failure, and 
19 from characterized graft versus host reacton. The cause of death of the remaining animals 
was not ascertained. 
sensitivity reactions were classified as "responder" guinea pigs and those with  consistently 
negative skin tests were classified as "nonresponder" guinea pigs. 
Irradiatlon.--Hartley  strain nonresponder recipient guinea pigs received 750 R  total body 
irradiation 24-48 hr before bone marrow transplantation. Animals were irradiated with a 200 
kv machine delivering 38.6 R/rain at a target distance of 45.5 cm using 1.0 mm aluminum and 
0.05 mm copper filters (HVL, half value layer, 1.3 ram Cu; F-0.94). In animals not protected 
with bone marrow cells,  this dose proved lethal  (see Table I),  as  had  been shown previ- 
ously (17). 
Strain 13 recipient guinea pigs were given 700 R  with two X-ray tubes at a distance of 54 
cm with a 250 kv machine. Conditions of irradiation were as follows: Voltage 200 kv, current 
15 ma, filter 0.25 mm Cu and 0.55 mm A1. HVL  =  0.91 mm Cu. Dose rate 139 R/min. This 
dose of irradiation is known to be uniformly lethal for strain 13 guinea pigs (18). All irradiated 
guinea pigs that did not receive a bone marrow transplant died within 12 days. 
Bone Marrow, Lymph Node, and Spleen Cell Transplants.--Hartley  guinea pigs were im- 
munized with GL in Dlfco complete adjuvant to determine their responder status as described 
above. Strain 13 or (2 X  13) F1 guinea pigs, to be used as donors of bone marrow or of lymph 
node and spleen cells,  were injected with complete Freund's adjuvant containing 0.5 mg/ml 
M. butyricum as a 1:1 emulsion prepared with physiological saline; 0.1 ml of the emulsion was 
injected into each footpad. This was done in order to stimulate the bone marrow and the 
lymphoid tissues and to increase cell yields. 10-14 days later the animals were  exsangulnated 
and the cell suspensions were prepared for transfer. 
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heart. Both tibiae, femora, and humeri were sterUely removed, the bone ends were snapped 
off with hemostats, and the contents of the marrow cavity were dislodged with a fine needle 
and flushed into Eagle's minimum medium containing i% guinea pig serum (MEM) with a 
Pasteur pipette. The dumps of marrow were dissociated into single cell suspensions by means 
of gently, and repeatedly, sucking the aggregates into Pasteur pipettes and discharging the 
contents back into the medium. The suspensions were then faltered  through two layers of 
gauze, centrifuged at 700 rpm for 5 rain, and resnspended in 2,5-3.0 ml of medium. All the 
bone marrow cells obtained from one donor were injected intravenously into a single recipient. 
The number of cells transferred are shown in the tables. The time interval between exsanguina- 
tion and suspension of cells in medium rarely exceeded 10 min,  and the cells were always in- 
jected into the recipient within 30-45 rain of removal from  the donor.  Some irradiated ani- 
reals, chosen at random, were injected with MEM only. 
Lymph node and spleen cell suspensions  were prepared  as follows: inguinal, axillary, and 
popllteal nodes and the spleen were removed sterilely. The lymph nodes and spleen were then 
teased apart with sharp instruments in 60 man plastic Petri dishes containing MEM, using 
sterile techniques. The stroma discarded, the teased cells were then gently tr~ng¢erred  with 
Pasteur pipettes to 12 nil conical centrifuge tubes to allow cen aggregates to settle spontane- 
ously. The isolated cells in the supematant were transferred again to 12 ml centrifuge tubes 
and spun at 700 rpm for 7 rain. The cells were then resuspended in 3-4 ml of MEM and slowly 
injected intravenously into irradiated  strain  13  recipients.  A  portion of the cells was  also 
removed for counting. This technique yielded cell suspensions from both lymph nodes and 
spleens containing a  large proportion of lymphoid cells; very few cells were identifiable as 
macrophages, as judged by uptake of neutral red into phagocytic vacuoles when exposed to 
1:20,000 concentration of the dye. In the experiments where the proportion of cells taking up 
neutral red,  and therefore identified as macrophages, were counted, they ranged from 0.25 
to 4% in the lymph node cell populations and from 1 to 8% in the spleen cell populations. A 
recipient animal received the lymph node and spleen cells from one donor guinea pig. 
The effects of radiation and of bone marrow and lymph node cell transplants  on survival 
are shown in Tables I  and II. All irradiated guinea pigs not protected with bone marrow died 
within 5-10 days. 95 irradiated nonresponder Hartley guinea pigs received bone marrow trans- 
plants.  Seven of these animals died of acute radiation sickness; seven more died of obvious 
graft  failure with  severe persisting pancytopenia.  19  guinea pigs  died  within  16-28  days 
(median 21 days) carrying all the stigmata of severe graft versus host reactions with wasting, 
extensive desquamating  dermatitis,  moderate  adenopathy,  and  diarrhea.  Several of these 
guinea pigs also showed a most interesting change in their blood leukocytes: striking elevations 
in the number of blood basophil polymorphonuclear leukocytes, in conjunction with severe 
graft versus host reactions, were observed. One animal, with no basophils prior to irradiation 
and bone marrow transfer, attained a count of 2500/ram  s just prior to death, while in several 
others the changes were less marked, but nevertheless highly significant. It was not established 
whether these basophils were of host or donor origin. The cause of death of the remaining 44 
guinea pigs was not precisely ascertained, although many of these animals also showed some 
evidence of graft versus host disease and  others  appeared  to be suffering from pulmonary 
infections (Table I). Thus, 75 of 95 irradiated animals died; 20 guinea pigs survived, and of 
these, 19 were in sufficiently good health to be included in the definitive experiments of the 
transfer of the ability to respond to DNP-PLL. The overall mortality was much lower when 
syngeneic or hemisyngeneic bone marrow transplants were used. Only 9 of 34 irradiated strain 
13  animals restored with strain  13 or (2  X  13)  F1 bone marrow died.  Syngeneic strain  13 
bone marrow gave significantly better protection than (2 X  13) F1 hybrid bone marrow. These 
data are presented in Table II. The animals that died displayed none of the clinical signs of 
graft versus host reaction. The surviving animals were in excellent condition at the time of 
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Immunization and Testing Procedures.--White  blood counts and differentials were done on 
Hartley strain survivors. After recovery from irradiation and cell transfers, transplant recipi- 
ents with an absohite lymphocyte count of 800/ram  8 of blood or higher were  immunized. 
Hartley recipient guinea pigs were injected with 100 #g/m1 of DNP-PLL in complete Freund's 
adjuvant containing 2 mg/ml of M. tubcrcuZos/s at times varying from 12 to 29 days a/ter bone 
marrow transplant. 0.1 ml of emulsion was injected into the right front and hind footpads. 
Strain 13 recipient animals were immunized either with 100 ~/ DNP-PLL  in adjuvants con- 
tainln~ 2 mg/ml M. tubereu/os/s H37 Rv or with 100 3' DNP-GL in adjuvants containing 0.5 
mg/ml M. bu~ic.um distributed in the four footpads. After the time intervals shown on the 
respective tables, the animals were skin tested for delayed hypersensitvity with 10 #g DNP- 
PLL or 50 #g of DNP-GL in 0.1 ml of saline. These concentrations of antigen caused only 
minimal irritation in uuimmunized animals. 
TABLE  II 
Relative Ability of Stragn 13 and  (Strain 2 X  Strain 13) Fi Bone Marrow  Cells to 
Protect Letkally Irradia~ (700 r) Strain 13 Guinea Pigs 
No. of recipient  Mortality st 2 months  Origin of bone marrow cells  ~nlmals 
% 
(2  X  13)Ft  14  ~4  4,3 
Strain 13  20  ~0  15 
Summary of all experiments  34  °/~  4  26 
All an;reals were then bled and their sera coLlected for antibody determination. In addition, 
in the Hartley recipient animals the lymph nodes draining the sites of injection of antigen 
(DNP-PLL) were collectod sterilely and the ability of their cells to proliferate in response to 
the immunizing antigen as manifested by increased DNA synthesis was investigated. The 
technique used has been described in detail previously (19). 
Levels of anti-DNP antibody were measured by a modification of the F arc technique (15). 
The binding of 8H-2,4-dinitrophenyl-e-aminocaproic acid (aH-DNP-EACA) by the globuiin 
fraction of the antisera was measured. SH-DNP-EACA was prepared as described in (14). The 
test was performed as follows: 0.1 ml of 10  -s M  SH DlXTP-EACA in PBS was added to 0.1 ml 
of serum in 10 ×  75 mm glass test tubes. This mixture was incubated for 1 hr at 4°C, then 
0.4 ml of 66% saturated ammonium sulfate solution was added. After mixing, the tubes were 
incubated again for 30 rain at 4°C. The samples were then spun at 2500 rpm in an International 
PR-2 centrifuge. 0.2 ml of the supematant was carefully withdrawn without disturbing the 
precipitate and added to a vial containing 10 ml of scintillation fluid. This was composed of: 
2365  ml toluene,  500 ml  Beckman Bio-Solv BBS3,  and  100 ml Liquifiuor,  New  England 
Nuclear Corp., Boston, Mass. The vials were then counted in a Liquid scintillation counter. A 
normal guinea pig serum as well as a  serum containing anti-DNP antibody was included in 
each assay. Control samples were prepared in which 0.1 ml PBS replaced the test sera. The 
per cent binding was calculated as follows: 
Counts  in  unknown  sera 
per cent  binding  ~  1  --Counts  in  control  samples X  100 
The binding value for normal nonimmune sera ranged from 0 to 7%. To relate the per cent 
binding to the actual amounts of anti-D~TP antibody in milligrams per milliliter, standard FOERSTERp GREEN~ LAMELIN~ AND BENACERRA]~  1113 
curves were constructed using individual strain 2 antisera from guinea pigs immunized with 
DNP-PLL or DNP-GL and bled 26 days after immunization (Fig. 1). The binding values for 
SH DNP-EACA of serial dilutions of these sera were plotted against the respective anti-DNP 
antibody concentrations of these dilutions. The anti-DNP antibody concentration of undiluted 
sera was measured by precipitin analysis with DNP-bovine fibrinogen as described (15). 
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FIG. I. Relationship between per cent of binding of IO-SM ~H DNP-EACA by serial dilu- 
tions of strain 2 guinea pig anti-DNP-GL 26 days sera and the concentrations of anti-DNP 
antibodies, measured by quantitative precipitin analysis. Values obtained with three different 
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RESULTS 
Tra~f~ of Responsiveness to DNP-PLL to Lethally Irrad~t~ Rartley strain 
Nonresponder Guinea Pigs by Bone Marrow  Transplants from  Allogeneic Re- 
sponder Harlley Guinea Pigs.- 
Bone marrow cells from responder  animals conferred upon irradiated non- 
responder  recipients  (previously  unable to make an immune response to GL) 
the ability to form an immune response to DNP-PLL (Table III). 13 of 14 non- 
responder Hartley guinea pigs carrying responder bone marrow grafts developed 
delayed hypersensitivity reactions when challenged with 10 #g of DNP-PLL 
after sensitization with this antigen. The lymph node ceils from 9 of 12 animals 
tested were also capable of responding to optimal concentrations of antigen in 
vitro, with increased thymidine  incorporation.  10 of 14 animals produced signifi- 
cant levels of antibody. Thus, 12 of 14 animals displayed immune responsiveness 
to DNP-PLL by at least two of the three parameters studied, while the remain- 
ing two animals (nos. 98, 100) had definite responses by one parameter each. In 
contrast, none of the nonresponder Hartley guinea pigs similarly grafted with 
nonresponder marrows were capable of mounting an immune response to DNP- 
PLL by any of the parameters studied (Table III). Of five animals,  none de- 
veloped delayed sensitivity to DNP-PLL after immunization with this antigen 
in complete  Freund's adjuvant, nor produced measurable levels of anti-DNP 
antibody; their lymph node cells exposed to DNP-PLL in vitro were not stimu- 
lated to proliferate. It should be noted that both the number of bone marrow 
ceils transferred and the levels of blood lymphocytes  on day of immunization are 
within the same range in the experimental and control groups. 
Some of the delayed hypersensitivity reactions  of the immunized irradiated 
nonresponder recipients  of responder marrow grafts were similar to those ob- 
served in immunized nonirradiated responder animals, but most reactions were 
less intense. The in vitro responses of lymph node ceils from such animals did not 
regularly reach  the levels previously observed  in responder  guinea pigs  (20). 
The lymph nodes of irradiated animals were small and may not have been ideal 
sources of immunocompetent ceils. Similarly, 4 of 14 transplanted animals did 
not produce significant  titers of anti-DNP  antibodies and the others did not 
attain the levels regularly seen in normal responder guinea pigs (4, 14, 15). The 
average serum concentration of anti-DNP antibodies observed in these animals, 
corresponding to 56.3 % binding of 8H DNP-EACA, was 0.17 mg/ml, as extrap- 
olated from the binding curve obtained with calibrated strain 2  anti-DNP- 
PLL sera. 
Transfer of Responsiveness to DNP-PLL and to DNP-GL to Lethally Irradiated 
Strain 13 Guinea Pigs by Bone Marrow or Lymph Node and Spleen Transplants 
from (2)< 13) Fx Animals.- 
All three lethally irradiated strain 13 guinea pigs reconstituted with strain 13 FOERSTER~  GRF.EN~ LAMELIN~  AND  BENACERRAF  1115 
TABLE  III 
Transfer of the Ability to Respond to DNP-PLL* to Lethally Irradiated Hartley Strain 
Nonresponder Guinea Pigs  with Bone Marrow Transplants from 
Hartley Strain  Guinea Pigs with the PLL Gene 
Recipient nonres~3onder 
guinea  pig ~o. 
Immune  response 
Lympho- 
Responder  Day of  ~-tes/mm s  Delayed sen-  •  •  Anti-DNP 
bone  marrow  immuniza-  ~.  /,~  Sttmulation  n""  "  O~  "  r  otooa  on  sitivity to  ¢ 1  h  a  UDOay  cellsX  1  Uonafte  ~  ..  o.  ym  ~  . 
transferred  transfer~Yiz°Itlimn  10/~gDNP-  --  I~,  percentbmd-  noae ceils  I  SHDNP 
PLLdlametersreaction  in vitro;~  ngEACA §  " 
mill 
2  (experimental)  18.0  15  6000  10  X  15  2.9  0 
47  7.6  14  2600  8  X  8  NRIi  59 
64  6.4  29  5300  9  X  9  NR  77 
73  5.5  18  2200  10  X  10  3.7  2 
77  10.0  17  3300  12  X  12  3.1  7 
83  6.1  27  2500  15  X  15  4.3  80 
85  4.6  27  2100  20  X  18  4.2  66 
87  5.8  15  1700  12  X  12  Neg  10 
91  10.8  14  1400  12  X  10  Neg  79 
98  5.6  13  1300  8  X  8  Neg  5 
100  4.8  24  3000  Neg  2.1  25 
102  5,1  24  1900  12  X  10  9.6  82 
103  8.9  24  2200  15  X  15  2.1  34 
104  6.8  24  3000  15  X  15  7.7  51 
Pos/total  13/14  9/12  10/14 
Mean value  7.57  2750  4.4  56.3 
Nonrespon- 
der bone 
Inarrow 
cells X  10  4 
transterred 
7 (controls)  10.5  21  1500  Neg  Neg  8 
26  12.6  22  4400  Neg  Neg  6 
30  11.8  21  2800  Neg  Neg  0 
107  5.5  13  800  Neg  Neg  3 
118  6.8  12  1100  Neg  Neg  7 
Pos/total  0/5  0/5  0/5 
Mean value  9.44  2120 
* Guinea pigs were immunized with 0.1 mg DNP-PLL  in complete adjuvant containing 
2 mg of M. turberculosls H37 Rv. 
This number is the ratio 
Counts in DNA from experimental cultures with 0.01 mg/ml DNP-PLL 
Counts in DNA from control cultures without antigen 
Values >  2 are considered significant. 
§ Per cent binding of 0.1 ml 10  -s x~ SH DNP-EACA by globulin fraction of 0.1 ml of serum. 
Values >  10% are outside range of nonspecific binding and are considered significant. 
i[ NR,  no result; contaminated cultures. 1116  TRANSFER  OF  RESPONSIVENESS 
bone marrow and (2 X  13) F1 lymph node and spleen cells made a specific im- 
mune response to DNP-PLL. All of these guinea pigs showed moderately strong 
delayed sensitivity reactions to DNP-PLL, and two of the animals also pro- 
duced high serum levels of anti-DNP  antibodies  (1.0 and  1.1 mg/ml).  Both 
lethally irradiated strain 13 guinea pigs given (2  X  13)  F1 bone marrow pro- 
duced moderate levels of anti-DNP antibodies, and one of these animals also 
developed delayed hypersensitivity to DNP-PLL  (Table IV). 
Table V presents the immune responses of the guinea pigs immunized with 
DNP-GL. 7 of 10 lethally irradiated strain 13 animals restored with strain 13 
bone marrow and (2  X  13) F1 lymph node and spleen cells made an  immune 
TABLE  IV 
Transfer of ~ke Ability to Respond to DNP-PLL* to Lethally Irradiated Strain 13 Recipients 
by Lymph Node and Spleen Cells or by Bone Marrow Cells/tom (Strain 2 X Strain 13)Ft 
Guinea Pigs 
Donor cells transferred X  10-s  Immune response 
Strain 13 
(2 X  13) FI  Delayed  Anti-DNP per  Serum sntl- 
recipient  Strain 15  (2 X  13) FI  lymph node  sensitivity to  cent blnding*H  gmnes pig  bone marrow bone marrow  bodi~es~  +  spleen  10~8 DNP-PLL  DNP-EACA~  mg/tml 
No. 
1  3.62  --  2.84  ++  90.5  1.1 
3  3.43  --  1.87  +++  0  -- 
5  6.07  --  3.44  ++  87.7  1.0 
2  --  6.00  --  Neg  69.8  0.62 
6  --  5.17  --  -l--t-  67.0  0.60 
* Recipient strain  13 guinea pigs were immunized with 0.1 nag DNP-PLL in complete 
Freund's adjuvant containing 2 mg/ml M. tuberculosis H37 Rv, 15 days after cell transfer. 
Per cent binding of 0.1 ml 10  -8 M DNP-EACA by globulin fraction of 0.1 ml of serum. 
§ Serum anti-DNP antibodies 18 days after immunization. 
[] Measured by quantitative precipitin analysis with DNP-bovine fibrinogen. 
response to DNP-GL, as shown by the formation of anti-DNP antibodies or the 
development of specific delayed hypersensitivity. The three animals that failed 
to respond received the lowest number of lymph node and spleen cells (less than 
3 X  10  8 cells). 
However, only one of six lethally irradiated strain 13 guinea pigs given (2 X 
13) FI bone marrow cells made a  strong immune response to DNP-GL. This 
animal developed both delayed hypersensitivity and a significant serum level of 
anti-DNP antibodies. Another animal had a very low serum concentration of 
anti-DNP  antibodies.  None of the four control lethally irradiated strain  13 
guinea pigs restored with only strain 13 bonemarrow made an immune response 
to DNP-GL. 
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to  DNP-PLL  or  DNP-GL  to  strain  13  guinea  pigs  with  (2  X  13)  FI 
cells is shown in Table VI. It is apparent  that lymph node and spleen cells axe 
TABLE  V 
Transfer  of the Ability to Respond to DNP-GL* to Lethally Irradiated  Strain 13 Recipien~ 
by Lymph Node and Spleen Cells or by Bone Marrow Cells  frora (Strain 2 X  Strain 13)  Ft 
Guinea Pigs 
Donor cells transferred X  lO-a  Immune response 
Anti-DNP antibodiest 
Strain  13  rm~..pient  Strain  13  (2  X 13)  Ft  (2  X 13)  FI Delayed  sensitivity 
guinea  plg  bone  bone  lymph node  to  50~LDIN-P-  per  cent 
marrow  marrow  -}- spleen  binding  QuantityU  aH DNP- 
EACA§ 
No.  diar,~ters (ram)  m~/ml 
10  3.70  --  2.46  Neg ¶  52  0.13 
13  12.00  --  3.12  10  X  8  60  0.21 
16  9.50  --  5.65  20  X  15  78  0.70 
19  4.68  ~  2.24  Neg  3  -- 
24  9.80  ~  4.80  7  X  6  4 
30  9.40  --  9.24  8  X  8  72  0.50 
34  4.70  --  11.30  7  X  7  67  0.32 
38  8.20  --  8.10  7 X  7  46  0.09 
40  7.80  ~  1.25  Neg  0 
42  9.60  ~  2.49  Neg  0 
11  --  14.00  ~  Neg  0  -- 
17  --  7.00  ~  Neg  0 
27  --  2.64  --  Neg  6  -- 
28  --  12.00  --  30 X  20  26  0.03 
29  --  10.50  --  Neg  9  0.01 
31  --  12.00  --  Neg  0  -- 
12 (control)  3.70  --  --  Neg  3 
15  "  9.10  --  --  Neg  2 
18  "  6.24  --  --  Neg  0 
21  "  6.24  --  --  Neg  6 
* Recipient strain 13 guinea pigs were immnnlzeA with 0.I mg DNP-GL  in complete 
Freund's adjuvant containing 0.5 mg/ml M. butyr~um 14-16 days after  cell  transfer. 
Serum anti-DNP antibodies 25 days after  immunlz.'ttion. 
§  Per cent binding of 0.1 ml l0 s  x~  DNP-EACA  by globulin  fraction  of  0.I ml of serum. 
]]  Values extrapolated from curve obtained with  calibrated  anti-DNP-GL sera  by  plotting 
per cent binding versus antibody concentration at various dilutions  (Fig.  I). 
¶ This animal  was ill  at time  of  skin  testing. 
more effective than bone marrow  cells for this purpose.  In the former situation 
10 of 13 animals made  an immune  response of one type or another, whereas in 
the latter case only 4 of 8  animals made an immune response. However, in every 
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was successful, the responses observed were not as intense as are regularly pro- 
duced by normal strain 2 responder guinea pigs immunized with these antigens. 
DISCUSSION 
The inability of genetically unresponsive guinea pigs to respond to DNP-PLL 
and to DNP-GL can be overcome by the transfer of cells from genetic responder 
animals. 
The ability to respond to DNP-PLL was transferred to lethally irradiated 
nonresponder Hartley strain guinea pigs with allogeneic bone marrow cells from 
guinea pigs with the PLL gene. The PLL responder status of the animals was 
established in these experiments from the response to previous immunization 
with GL, a copolymer, the immunogenicity of which is also controlled by the 
TABLE  VI 
Analysis  of the Transfers of the Ability  to Respond to DNP-PLL or to DNP-GL  to 
Lethally Irradiated Strain 13 Guinea Pigs with Cells  from (Strain 2 X  Strain 13)F1 
Guinea Pigs 
Number of guinea pigs displaying immune 
response to DNP-PLL or to DNP-GL 
No. strain  Delayed 
Origin of donor cells  13 recipients  Delayed  Anti- DNP  sensitivity 
sensitivity  antibody  or anti-DNP 
antibody 
Strain 13 bone marrow (control)  4  0  0  0 
(2 X 13) F1 bone marrow  8  2  4  4 
(2 X 13) F1 lymph node +  spleen  13  9  8  10 
PLL gene (4). Similarly, the ability to respond to DNP-PLL and to DNP-GL 
was transferred to lethally irradiated strain 13 guinea pigs which normally do 
not respond to these antigens with (2 X  13) F1 bone marrow cells. 
The immune response elicited by DNP-PLL in most irradiated nonresponder 
recipients after the transfer of bone marrow cells from animals with the PLL 
gene was characterized by delayed hypersensitivity and other evidence of cellu- 
lar immunity to DNP-PLL, as well as by the synthesis of significant levels of 
anti-DNP antibodies. Although positively charged DNP-PLL can behave as a 
hapten in nonresponder guinea pigs, and elicit the formation of anti-DNP anti- 
bodies when associated with a variety of immunogenic carriers (14,  15), DNP- 
PLL has never been able to elicit delayed sensitivity in either Hartley strain or 
strain 13 nonresponder guinea pigs, nor has it been able to stimulate the pro- 
liferation of their lymph node cells in vitro (14, 15, 20). These experiments there- 
fore establish conclusively that the ability to recognize hapten-PLL conjugates 
as antigens can be transferred to guinea pigs lacking the PLL gene, and that the 
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These studies also demonstrate that the inability of nonresponder guinea pigs to 
recognize PLL antigens is not due to nonspecific nonimmunological mecha- 
nisms. The bone marrow is known to contain precursors of many cell types with 
diverse functions. In addition to hematopoietic ceils  without immunological 
roles, bone marrow also gives rise to macrophages (21, 22) and lymphocytes and 
is thought by some to be the source of all immunocompetent ceils (23, 24). 
However, in a second series of experiments, the ability to respond to DNP- 
PLL and to DNP-GL was also transferred to lethally irradiated strain 13 guinea 
pigs with lymph node and spleen cell populations from (2 X  13) F1 responder 
guinea pigs. (2 X  13) FI lymph node and spleen cells were generally more suc- 
cessful than (2 X  13) F1 bone marrow in conferring responsiveness to PLL anti- 
gens to strian 13 guinea pigs. This finding suggests that the essential cells in 
which the PLL gene is expressed may be a lymphocyte of one kind or another, 
rather  than  a  monocyte or macrophage.  Bone marrow  cell populations are 
known to contain a larger number of monocyte precursors than do lymph node 
cell populations (25). The number of macrophages in the lymph node and spleen 
cell populations transferred can be considered to average less than 4%. How- 
ever, a definitive identification of the precise cell types responsible for the trans- 
fer of the ability to respond to PLL antigens must await the result of transfer 
experiments with purified cell populations. These studies are now in progress.  It 
would also be of considerable interest  to  ascertain  whether  the  cells  which 
produced  anti-DNP  antibodies  or  which mediated  cellular hypersensitivity 
reactions against PLL antigens in lethally irradiated strain 13 guinea pigs immu- 
nologically restored with (2 X  13) F1 cells, are of donor or host origin. Unfor- 
tunately, the unavailability of suitable allotype markers on guinea pig immu- 
noglobulins did not permit this study to be made. It is possible, however, that 
sera directed respectively against strain 2 and strain 13 histocompatibility anti- 
antigens may be produced and used for this purpose. 
The ability to transfer immune reactivity to PLL antigens from nonimmu- 
nized donor responder animals to lethally irradiated nonresponder guinea pigs is 
at first glance at variance with previous observations from our laboratory. These 
previous studies had demonstrated that the classical passive transfer of delayed 
sensitivity to DNP-PLL and DNP-GL could, with rare exception, be success- 
fully accomplished in random-bred Hartley strain guinea pigs only by transfer- 
ring sensitized cells  from immunized responder animals into other responder 
guinea pigs (26). Transfer of these cell populations into nonresponder guinea pigs 
failed, in the great majority of cases, to passively transfer delayed sensitization. 
This type of result has also been observed by Battisto et ai. with another im- 
mune system (27). 
There is as yet no satisfactory explanation for these differences. However, the 
two types of transfer experiments are very different and their results may still 
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mals, it appears that all the cell types necessary for an immune response to PLL 
antigens were transferred and also given a sufficient time to mature and pro- 
liferate in a favorable environment (at least 21 days). Thus, in the transfer of 
the ability to respond to PLL antigens, the nonresponder recipient animals had 
enough time to accumulate all the required donor cell types at the time of im- 
munization. On the other hand, the difficulty  in transferring delayed sensitivity 
passively from responder to nonresponder  guinea pigs imply either that in this 
experimental situation the sensitized cells transferred were not capable to elicit 
the reaction by themselves  and required  an active participation by host cells 
with the same genetic makeup to elicit a specific reaction at the site of injection 
of the PLL antigens, or that the sensitized cells from Hartley strain responder 
guinea pigs  found a  less favorable environment in  allogeneic nonresponder 
guinea pigs. Whatever the explanation for the failure to passively transfer de- 
layed sensitivity in the PLL system from responder  to nonresponder  guinea 
pigs, the experiments  presented in this study establish  unequivocally that the 
ability to form an immune response to antigens whose immunogenicity is con- 
trolled by the PLL gene can be effectively transferred to lethally irradiated non- 
responder guinea pigs with cell populations known to be concerned with immune 
responsiveness. The data presented are also compatible with the interpretation 
that the cell type or types responsible are some classes of lymphocytes  present in 
the bone marrow and in larger numbers in lymph  nodes and spleen. Furthermore, 
the transfer of the ability to respond to PLL antigens is comparable to the find- 
ing of Tyan et al. (13) on the successful transfer of responsiveness to (TG)-A-L 
from responder mice into nonresponder mice with spleen cells or fetal liver cells, 
and illustrates the similarities  presented by these two immune systems where 
specific, though complex, immune responses have been shown to be under the 
control of dominant genetic factors. 
SUMMARY 
Hartley guinea pigs genetically unresponsive  to hapten-PLL (poly-L-lysine) 
conjugates were lethally irradiated and given  allogeneic bone marrow from 
Hartley responder  animals. Many of the animals died of graft versus host dis- 
ease  before  their  response  to  2,4-dinitrophenyl-PLL (DNP-PLL)  could  be 
measured. The immune response of the surviving recipient  animals  was eval- 
uated by anti-DNP antibody production, development of delayed hypersen- 
sitivity to  DNP-poly-L-lysine,  as well  as by lymph node cell  stimulation in 
vitro by this antigen. 12 of 14 recipient  animals thus treated made an immune 
response as measured by 2 of the 3 parameters. 
Strain 13 guinea pigs, genetically  unable to respond immunologicaily to DNP- 
PLL and to DNP-GL (2,4-dinitrophenyl-L-glutamic  acid L-lysine copolymer) 
were lethally irradiated and given bone marrow from (2)<  13)  F1 responder 
animals  or strain 13  bone marrow and (2  X  13)  F1 lymph node and spleen 
cells. A high proportion of the animals  survived this procedure;  no evidence FOERSTER, GREEN~ LAM.ELIN; AND BENACE1LRA~'  1121 
of graft versus host disease was  observed. Three of three strain  13  animals 
irradiated and, given strain 13 bone marrow and (2  X  13) F1 lymph node and 
spleen, and then immunized with DNP-PLL, made a specific immune response. 
7 of 10 irradiated strain 13 animals given strain 13 bone marrow and ( 2 X  13) 
F1 lymph node and spleen made an immune response to DNP-GL. However, 
only one of six irradiated strain 13 animals made a vigorous immune response 
to DNP-GL after reconstitution with (2 X  13) F1 bone marrow alone. 
The ability to transfer the immune response to PLL antigens from responder 
to nonresponder animals demonstrates unequivocally that the defect in the non- 
responder animals is immunological rather than due to some other type of non- 
immunological mechanism. The bone marrow contains all the immunological 
cells necessary for the expression of the PLL gene. However, the finding that 
(2 X  13) FI lymph node and spleen cells were more effective than (2 X  13)F1 
bone marrow cell populations (known to be a rich source of monocyte precur- 
sors) suggests that the cells in which the PLL gene function is expressed may be 
lymphocytes rather than monocytes and macrophages. 
The authors wish to thank Mrs. Clara Lee Horton and Mr. Edmond Goidl for their val- 
uable technical assistance. 
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